Results 211 to 220 of about 4,979,977 (315)

Estimated Body Fat Percentage and Triglyceride‐Glucose Index for Identifying MASLD in Lean Asian Adults: A Cross‐Sectional Analysis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) is increasingly prevalent among lean Asian populations, yet effective strategies for identifying high‐risk individuals remain limited. We investigated the associations of body fat percentage (BF%) and the triglyceride‐glucose (TyG) index with lean MASLD and evaluated their ...
Xiang‐Ran Kong, Ya‐Li Chen, Rui Li, Lu‐Xiang Shang, Sha Sha   +4 more
wiley   +1 more source

Cardiometabolic Disease Education and Health Services Among Public High Schools.

JAMA Netw Open
Zaganjor I, Saelee R, Sekkarie A, Pavkov ME, Koyama AK, Choi JH, Onufrak S, Choi D, Han S, Krause KH.   +9 more
europepmc   +1 more source

Association and Discriminative Performance of a Body Shape Index (ABSI) for Cardiometabolic Disease in a Korean Population. [PDF]

Healthcare (Basel)
Seo MW, Kim JY.
europepmc   +1 more source

Interactive Roles of Metabolic Dysfunction‐Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The prognostic effect of concurrent metabolic dysfunction‐associated steatotic liver disease (MASLD) on outcomes for hepatocellular carcinoma (HCC) patients remains unclear. The Prognostic Nutritional Index (PNI) reflects nutritional and inflammatory status and is a well‐known prognostic factor.
Chun‐Ting Ho, Chien‐An Liu, Chia‐Jung Ho, Yi‐Chen Lin, Shin‐Yu Tsai, Hao‐Jan Lei, Shu‐Cheng Chou, Yi‐Hsiang Huang, Ming‐Chih Hou, Jaw‐Ching Wu, Chien‐Wei Su   +10 more
wiley   +1 more source

Childhood Obesity and the Future Burden of Adult Cardiometabolic Disease: A Narrative Review. [PDF]

Cureus
Balakrishna H, Ajith A, Sasi S, Sukumaran SM.   +3 more
europepmc   +1 more source

Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction‐Associated Steatotic Liver Disease

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The impacts of cardiometabolic risk factors (CMRFs) and the biomarkers on disease severity in metabolic dysfunction‐associated steatotic liver disease (MASLD) remain elusive. Accordingly, a multicenter study by recruiting MASLD patients from a nationwide registry database was conducted with a total of 2882 MASLD patients (54.1% males, mean age 
Jee‐Fu Huang, Chi‐Yi Chen, Ming‐Jong Bair, Tzu‐Chun Lin, Ming‐Lun Yeh, Pei‐Chien Tsai, Yu‐Ju Wei, Chih‐Wen Wang, Po‐Chen Liang, Ming‐Yen Hsieh, Mei‐Hsuan Lee, Chia‐Yen Dai, Chung‐Feng Huang, Ming‐Lung Yu, Wan‐Long Chuang   +14 more
wiley   +1 more source

Association Between Clonal Hematopoiesis and Cardiometabolic Disease: A Systematic Review and Meta-Analysis. [PDF]

JACC CardioOncol
D'Mello B, Sheth N, Orchanian-Cheff A, Soave D, Abelson S, Woo M, Ke C.   +6 more
europepmc   +1 more source

Depressive Symptoms, sleep Disturbance, and Cardiometabolic Multimorbidity Among Adults With Arthritis: A Cross‐Sectional Analysis of NHANES 2013–2020

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT While the association between depressive symptoms and cardiometabolic disease is well established, the relationships among depressive symptoms, sleep disturbance, and cardiometabolic multimorbidity (CMM) in adults with arthritis remain insufficiently understood.
Lu‐Niao Ma, Jing‐Cheng Jiang, Jun‐Jie Lan, Yang‐Yang Chen, Hui‐Min Zhang, Yao Zeng, Xu‐Hui Huang, Xiao‐Na Tang   +7 more
wiley   +1 more source

Trends in cardiometabolic disease and health-related quality of life in the United States, 2001-2022. [PDF]

Qual Life Res
Yang D, Kim DD.
europepmc   +1 more source

Stage‐Dependent Prognostic Value of the Joint MASLD–NAFLD Fibrosis Score Phenotype Across the Cardiovascular–Kidney–Metabolic Syndrome Continuum: A Retrospective NHANES Cohort Analysis, 1999–2018

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The cardiovascular–kidney–metabolic (CKM) framework and metabolic dysfunction–associated steatotic liver disease (MASLD) describe a shared clinical continuum, but the prognostic value of joint fatty liver index (FLI)–NAFLD fibrosis score (NFS) phenotypes across CKM stages is uncertain.
Yi‐Fei Wang, Jian‐Li Zhang, Yun‐Fei Wang, Jun‐Peng Xiong, Rong‐Hui Yu, Ze‐Ping Hu   +5 more
wiley   +1 more source